BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24276037)

  • 1. Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working party.
    Kim BE; Koh KN; Suh JK; Im HJ; Song JS; Lee JW; Kang HJ; Park KD; Shin HY; Choi HS; Lee SH; Yoo KH; Sung KW; Koo HH; Jung HL; Chung NG; Cho B; Kim HK; Lyu CJ; Baek HJ; Kook H; Park JE; Park HJ; Park BK; Yoo ES; Ryu KH; Lee KS; Kim HS; Lee JM; Park ES; Yoon HS; Lee KC; Lee MJ; Lim YT; Kim HM; Park SK; Park JA; Kim SK; Park M; Lim YJ; Lee YH; Seo JJ;
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):125-33. PubMed ID: 24276037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
    Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
    Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.
    Aricò M; Astigarraga I; Braier J; Donadieu J; Gadner H; Glogova E; Grois N; Henter JI; Janka G; McClain KL; Ladisch S; Pötschger U; Rosso D; Thiem E; Weitzman S; Windebank K; Minkov M;
    Br J Haematol; 2015 Apr; 169(2):241-8. PubMed ID: 25522229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome.
    Ronceray L; Pötschger U; Janka G; Gadner H; Minkov M;
    J Pediatr; 2012 Jul; 161(1):129-33.e1-3. PubMed ID: 22284564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical manifestations of Langerhans cell histiocytosis with multisystem involvement in 53 children].
    Tang JJ; Xu XJ; Wang YC; Bai ST; Wang L; Ni XL; Liu YF
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):37-41. PubMed ID: 33397002
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
    Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
    Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
    Narula G; Pradhan ND; Arora B; Banavali SD
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis in neonates.
    Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
    Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
    Wu FF; Gao YJ; Pan C; Chen J; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
    Gadner H; Minkov M; Grois N; Pötschger U; Thiem E; Aricò M; Astigarraga I; Braier J; Donadieu J; Henter JI; Janka-Schaub G; McClain KL; Weitzman S; Windebank K; Ladisch S;
    Blood; 2013 Jun; 121(25):5006-14. PubMed ID: 23589673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans Cell Histiocytosis: Single Center Experience of 25 Years.
    Tuysuz G; Yildiz I; Ozdemir N; Adaletli I; Kurugoglu S; Apak H; Dervisoglu S; Bozkurt S; Celkan T
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019035. PubMed ID: 31205639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
    Tantawy AAG; Ragab IA; Elsherif NHK; Makkeyah SM; AbdelRaheem HG; Elsantiel HIE
    Pediatr Hematol Oncol; 2020 Nov; 37(8):696-706. PubMed ID: 32706277
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry.
    Minkov M; Steiner M; Pötschger U; Aricò M; Braier J; Donadieu J; Grois N; Henter JI; Janka G; McClain K; Weitzman S; Windebank K; Ladisch S; Gadner H;
    J Pediatr; 2008 Nov; 153(5):700-5, 705.e1-2. PubMed ID: 18589441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
    Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
    Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cell histiocytosis: a retrospective analysis in a Korean tertiary hospital from 2003 to 2012.
    Kwon SH; Choi JW; Kim HJ; Youn SW
    J Dermatol; 2013 Oct; 40(10):824-8. PubMed ID: 23957667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis.
    Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R
    Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
    Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
    Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.